HOBOKEN, New Jersey, March 7 -- Diabetes, Obesity and Metabolism, a journal that says it focuses on clinical and experimental pharmacology and therapeutics in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems, published research articles on the following topics in its April 2023 edition:

REVIEW ARTICLES:

* Early type 2 diabetes treatment intensification with glucagon-like peptide-1 receptor agonists in primary care: An Austr . . .

Click here for more information about our products